Account Executive at Bristol-Myers Squibb

Kaohsiung, Kaohsiung City, Taiwan

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, HematologyIndustries

Requirements

Degree in science or related professional qualification
3+ years sales experience in pharmaceutical industry
Sales experience in Hema-Oncology or specialty drugs is preferred
New product launch and/or self-paid product experience is preferred
Able to perform account analysis to identify issue/opportunity in assigned territory
Good communication skill and positive working attitude with passion
Able to work independently, self-motivated & result-oriented

Responsibilities

Successful and on schedule listing Hema-Oncology Products in assigned territory
Achieve sales target and brand objective through developing and implementing brand strategy and sales execution plan in the territory
Build strong connections with targeted customers and gain their insights in marketplace
Analyze, perform and implement self-paid program and micro-marketing plan based on individual account needs and in align with brand strategy
Collaborate with fellow team members to conduct CME programs in fulfilling brand advocates development
Perform territory management functions in serving existing customers and prioritizing resource allocation based on opportunity/issue identified from account analysis
Strategizing sales territory plan, execution and checking to drive business growth with applying compliance

Skills

sales strategy

territory management

account management

brand strategy

sales execution

market analysis

customer relationship management

CME programs

hematology sales

oncology products

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free